Testing effectiveness (Phase 2)Ended earlyNCT01372813What this trial is testingVandetanib to Treat Advanced Kidney CancerWho this might be right forAdvanced Clear Cell Renal Carcinoma National Cancer Institute (NCI) 3
Not applicableStudy completedNCT00088803What this trial is testingDNA Variations in the Gene in Young Patients With Wilms' TumorWho this might be right forKidney Cancer Children's Oncology Group 471
Testing effectiveness (Phase 2)Study completedNCT00006486What this trial is testingCarboxyamidotriazole in Treating Patients With Metastatic Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 335
Not applicableLooking for participantsNCT05060783What this trial is testingRenal Cancer Detection With Liquid BiopsyWho this might be right forRenal CancerOncocytoma Zealand University Hospital 200
Early research (Phase 1)Looking for participantsNCT07300241What this trial is testingOpen-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more Neomorph, Inc 30
Not applicableStudy completedNCT04006405What this trial is testingAURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCCWho this might be right forClear Cell Renal Cell Carcinoma Elypta 280
Testing effectiveness (Phase 2)Study completedNCT03581773What this trial is testingFolic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted TherapyWho this might be right forMucositisStomatitis Niels Fristrup 84
Testing effectiveness (Phase 2)Study completedNCT03149822What this trial is testingStudy of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma University of Colorado, Denver 45
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Testing effectiveness (Phase 2)Study completedNCT01510119What this trial is testingAutophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell CarcinomaWho this might be right forMetastatic Clear Cell Renal Cell Carcinoma Abramson Cancer Center at Penn Medicine 40
Early research (Phase 1)Study completedNCT04504669What this trial is testingFirst Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more AstraZeneca 60
Not applicableStudy completedNCT04213157What this trial is testingLaparoscopic Partial Nephrectomy for cT1 TumorsWho this might be right forRenal CancerRenal NeoplasmRenal Cell Carcinoma+10 more Samsun Liv Hospital 292
Early research (Phase 1)Study completedNCT00016237What this trial is testingInterleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous TreatmentWho this might be right forBladder CancerKidney CancerLung Cancer EMD Serono
Not applicableLooking for participantsNCT05403177What this trial is testingMarathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)Who this might be right forBreast CancerColorectal CancerPancreas Cancer+9 more University Health Network, Toronto 500
Early research (Phase 1)Study completedNCT00056537What this trial is testingABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic CancerWho this might be right forNon-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer Active Biotech AB 44
Early research (Phase 1)Looking for participantsNCT05536141What this trial is testingAB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaSolid Tumors Arcus Biosciences, Inc. 362
Testing effectiveness (Phase 2)Looking for participantsNCT07223541What this trial is testingCemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma University of Oklahoma 72
Not applicableStudy completedNCT02228954What this trial is testingIMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)Who this might be right forClear-cell Metastatic Renal Cell CarcinomaKidney Neoplasms Radboud University Medical Center 40
Not applicableUnknownNCT03694912What this trial is testingDevelopment and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular BiomarkersWho this might be right forClear Renal Cell Cancer (< 7cm Size) Yonsei University 426
Not applicableStudy completedNCT06883565What this trial is testingTertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort StudyWho this might be right forRenal Cell Carcinoma (RCC) Ding-Wei Ye 232